Nonpharmacologic Treatments for Attention-Deficit/Hyperactivity Disorder: A Systematic Review

被引:41
|
作者
Goode, Adam P. [4 ,5 ]
Coeytaux, Remy R. [7 ,8 ]
Maslow, Gary R. [1 ,2 ]
Davis, Naomi [1 ]
Hill, Sherika [1 ]
Namdari, Behrouz [1 ]
LaPointe, Nancy M. Allen [3 ,9 ]
Befus, Deanna [8 ]
Lallinger, Kathryn R. [5 ,10 ]
Bowen, Samantha E. [6 ]
Kosinski, Andrzej [5 ]
McBroom, Amanda J. [5 ,10 ]
Sanders, Gillian D. [5 ,10 ]
Kemper, Alex R. [11 ]
机构
[1] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA
[2] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA
[3] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[4] Duke Univ, Sch Med, Duke Orthopaed Surg, Durham, NC 27706 USA
[5] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
[6] Duke Univ, Sch Med, Duke Ctr Autism & Brain Dev, Durham, NC 27706 USA
[7] Wake Forest Univ, Sch Med, Dept Family & Community Med, Winston Salem, NC 27109 USA
[8] Wake Forest Univ, Sch Med, Ctr Integrat Med, Winston Salem, NC 27109 USA
[9] Premier Inc, Charlotte, NC USA
[10] Duke Evidence Based Practice Ctr, Durham, NC USA
[11] Nationwide Childrens Hosp, Div Ambulatory Pediat, 700 Childrens Dr,LAC5411, Columbus, OH 43205 USA
基金
美国医疗保健研究与质量局;
关键词
DEFICIT HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED TRIAL; FAMILY-SCHOOL INTERVENTION; RANDOMIZED CLINICAL-TRIAL; PROSPECTIVE FOLLOW-UP; OMEGA3; FATTY-ACIDS; DOUBLE-BLIND; YOUNG-CHILDREN; PSYCHOEDUCATION PROGRAM; GINKGO-BILOBA;
D O I
10.1542/peds.2018-0094
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
CONTEXT: Nonpharmacologic treatments for attention-deficit/hyperactivity disorder (ADHD) encompass a range of care approaches from structured behavioral interventions to complementary medicines. OBJECTIVES: To assess the comparative effectiveness of nonpharmacologic treatments for ADHD among individuals 17 years of age and younger. DATA SOURCES: PubMed, Embase, PsycINFO, and Cochrane Database of Systematic Reviews for relevant English-language studies published from January 1, 2009 through November 7, 2016. STUDY SELECTION: We included studies that compared any ADHD nonpharmacologic treatment strategy with placebo, pharmacologic, or another nonpharmacologic treatment. DATA EXTRACTION: Study design, patient characteristics, intervention approaches, follow-up times, and outcomes were abstracted. For comparisons with at least 3 similar studies, random-effects meta-analysis was used to generate pooled estimates. RESULTS: We identified 54 studies of nonpharmacologic treatments, including neurofeedback, cognitive training, cognitive behavioral therapy, child or parent training, dietary omega fatty acid supplementation, and herbal and/or dietary approaches. No new guidance was identified regarding the comparative effectiveness of nonpharmacologic treatments. Pooled results for omega fatty acids found no significant effects for parent rating of ADHD total symptoms (n = 411; standardized mean difference -0.32; 95% confidence interval -0.80 to 0.15; I-2 = 52.4%; P = .10) or teacher-rated total ADHD symptoms (n = 287; standardized mean difference -0.08; 95% confidence interval -0.47 to 0.32; I-2 = 0.0%; P = .56). LIMITATIONS: Studies often did not reflect the primary care setting and had short follow-up periods, small sample sizes, variations in outcomes, and inconsistent reporting of comparative statistical analyses. CONCLUSIONS: Despite wide use, there are significant gaps in knowledge regarding the effectiveness of ADHD nonpharmacologic treatments.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Early motor signs of attention-deficit hyperactivity disorder: a systematic review
    Athanasiadou, A.
    Buitelaar, J. K.
    Brovedani, P.
    Chorna, O.
    Fulceri, F.
    Guzzetta, A.
    Scattoni, Maria Luisa
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2020, 29 (07) : 903 - 916
  • [22] Global Economic Burden of Attention-Deficit/Hyperactivity Disorder: A Systematic Review
    Chhibber, Anindit
    Watanabe, Alexandre Hikiji
    Chaisai, Chayutthaphong
    Veettil, Sajesh K.
    Chaiyakunapruk, Nathorn
    PHARMACOECONOMICS, 2021, 39 (04) : 399 - 420
  • [23] Systematic review of gut microbiota and attention-deficit hyperactivity disorder (ADHD)
    Sukmajaya, Alverina Cynthia
    Lusida, Maria Inge
    Soetjipto
    Setiawati, Yunias
    ANNALS OF GENERAL PSYCHIATRY, 2021, 20 (01)
  • [24] The Association between Lead and Attention-Deficit/Hyperactivity Disorder: A Systematic Review
    Donzelli, Gabriele
    Carducci, Annalaura
    Llopis-Gonzalez, Agustin
    Verani, Marco
    Llopis-Morales, Agustin
    Cioni, Lorenzo
    Morales-Suarez-Varela, Maria
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (03)
  • [25] Attention-Deficit/Hyperactivity Disorder and Outcome After Concussion: A Systematic Review
    Cook, Nathan E.
    Iaccarino, Mary Alexis
    Karr, Justin E.
    Iverson, Grant L.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2020, 41 (07) : 571 - 582
  • [26] A Review of OROS Methylphenidate (Concerta®) in the Treatment of Attention-Deficit/Hyperactivity Disorder
    Katzman, Martin A.
    Sternat, Tia
    CNS DRUGS, 2014, 28 (11) : 1005 - 1033
  • [27] Gender differences in adults with attention-deficit/hyperactivity disorder: A narrative review
    Williamson, David
    Johnston, Charlotte
    CLINICAL PSYCHOLOGY REVIEW, 2015, 40 : 15 - 27
  • [28] A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
    Sharma, Alok
    Couture, Justin
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (02) : 209 - 225
  • [29] Pharmacological Treatments for Attention-Deficit Hyperactivity Disorder (ADHD) in Adults: A Systematic Review and Meta-analysis
    Charernboon, Lampu
    Kosulwit, Winitra
    ARCHIVES OF CLINICAL PSYCHIATRY, 2023, 50 (01) : 150 - 156
  • [30] Systematic review of mitochondrial genetic variation in attention-deficit/hyperactivity disorder
    Giannoulis, Stavroula, V
    Mueller, Daniel
    Kennedy, James L.
    Goncalves, Vanessa
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024, 33 (06) : 1675 - 1685